2017
DOI: 10.1016/j.nicl.2016.12.022
|View full text |Cite
|
Sign up to set email alerts
|

Right inferior frontal cortex activity correlates with tolcapone responsivity in problem and pathological gamblers

Abstract: Failures of self-regulation in problem and pathological gambling (PPG) are thought to emerge from failures of top-down control, reflected neurophysiologically in a reduced capacity of prefrontal cortex to influence activity within subcortical structures. In patients with addictions, these impairments have been argued to alter evaluation of reward within dopaminergic neuromodulatory systems. Previously we demonstrated that augmenting dopamine tone in frontal cortex via use of tolcapone, an inhibitor of the dopa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
18
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 16 publications
(21 citation statements)
references
References 52 publications
3
18
0
Order By: Relevance
“…This form of control is thought to be instantiated by prefrontal and other higher-order cortical influences over subcortical brain regions including the striatum (e.g. (66,(81)(82)(83)). By this hypothesis, augmenting prefrontal control by whatever means should improve goal-oriented behaviors.…”
Section: Working Memorymentioning
confidence: 99%
“…This form of control is thought to be instantiated by prefrontal and other higher-order cortical influences over subcortical brain regions including the striatum (e.g. (66,(81)(82)(83)). By this hypothesis, augmenting prefrontal control by whatever means should improve goal-oriented behaviors.…”
Section: Working Memorymentioning
confidence: 99%
“…Subjects were administered either 200 mg tolcapone or placebo in a randomized, double-blind, counterbalanced, crossover design. This dose of tolcapone was selected based on our previously published findings indicating that a single 200 mg tolcapone dose produces reliable behavioral results without significant or consistent side effects (Cameron et al 2018;Kayser et al 2012;Kayser et al 2015;Kayser et al 2017;Saez et al 2015). Order was assigned using standard random allocation sequence-generating software by a study investigator who did not otherwise have contact with subjects.…”
Section: Subjectsmentioning
confidence: 99%
“…These studies suggest that increasing dopamine in prefrontal cortex may correspondingly improve time perception, and that this improvement may be mediated by changes in top-down control over behavior (i.e., via altered connectivity between relevant prefrontal regions and the striatum). Because the FDAapproved COMT inhibitor tolcapone acts to preferentially augment dopamine tone in frontal regions of the brain (Doudet et al 1997), this medication may be useful in assessing this hypothesis, especially as previous work has shown that tolcapone can improve behavioral self-regulation and, correspondingly, alter the magnitude of correlations between frontal and striatal brain areas (Kayser et al 2012;Kayser et al 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Subjects were administered either 200 mg tolcapone or placebo in a randomized, double-blind, counterbalanced, crossover design. This dose of tolcapone was selected based on our previously published findings indicating that a single 200 mg tolcapone dose produces reliable behavioral results without significant or consistent side effects (Cameron et al 2018 ; Kayser et al 2012 ; Kayser et al 2015 ; Kayser et al 2017 ;Saez et al 2015 ). Order was assigned using standard random allocation sequence-generating software by a study investigator who did not otherwise have contact with subjects.…”
Section: Methodsmentioning
confidence: 99%
“…These studies suggest that increasing dopamine in prefrontal cortex may correspondingly improve time perception, and that this improvement may be mediated by changes in top-down control over behavior (i.e., via altered connectivity between relevant prefrontal regions and the striatum). Because the FDA-approved COMT inhibitor tolcapone acts to preferentially augment dopamine tone in frontal regions of the brain (Doudet et al 1997 ), this medication may be useful in assessing this hypothesis, especially as previous work has shown that tolcapone can improve behavioral self-regulation and, correspondingly, alter the magnitude of correlations between frontal and striatal brain areas (Kayser et al 2012 ; Kayser et al 2017 ).…”
Section: Introductionmentioning
confidence: 99%